ARCHIVES

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

This article is from The Cancer Letter archive.

Vol. 13 No. 02 | January 9, 1987

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

Hopkins Oncology Center Renamed To Honor Sidney Kimmel

May 10, 2002

Giaccone Joins Georgetown Lombardi Center

February 22, 2013

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002